End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.56 CNY | +0.36% | -6.24% | -22.67% |
Feb. 02 | Zhejiang Hisoar Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 300 million worth of its shares. | CI |
Feb. 02 | Hisoar Pharma Chairman Plans Up to 20 Million Yuan Investment | MT |
Sales 2021 | 2.48B 344M | Sales 2022 | 2.7B 374M | Capitalization | 11.35B 1.57B |
---|---|---|---|---|---|
Net income 2021 | 95M 13.15M | Net income 2022 | 88M 12.18M | EV / Sales 2021 | 4.87 x |
Net cash position 2021 | 1.24B 172M | Net cash position 2022 | 489M 67.71M | EV / Sales 2022 | 4.02 x |
P/E ratio 2021 |
137
x | P/E ratio 2022 |
140
x | Employees | 2,788 |
Yield 2021 |
1.21% | Yield 2022 |
0.71% | Free-Float | 51.53% |
1 day | +0.36% | ||
1 week | -6.24% | ||
Current month | +0.18% | ||
1 month | +1.28% | ||
3 months | -19.88% | ||
6 months | -35.35% | ||
Current year | -22.67% |
Managers | Title | Age | Since |
---|---|---|---|
Guo Rui Xu
CEO | Chief Executive Officer | 47 | 99-12-31 |
Bing Yao
DFI | Director of Finance/CFO | 42 | 19-11-12 |
Jin Yun Hu
BRD | Director/Board Member | 51 | 99-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Zhong Gong
BRD | Director/Board Member | 58 | 07-06-30 |
Guo Rui Xu
CEO | Chief Executive Officer | 47 | 99-12-31 |
Bing Yao
DFI | Director of Finance/CFO | 42 | 19-11-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 30 M€ | +5.59% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 5.56 | +0.36% | 7,222,300 |
24-03-27 | 5.54 | -1.25% | 8,011,301 |
24-03-26 | 5.61 | -1.41% | 6,837,064 |
24-03-25 | 5.69 | -2.74% | 6,423,208 |
24-03-22 | 5.85 | -1.35% | 8,957,939 |
End-of-day quote Shenzhen S.E., March 27, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.67% | 1.25B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |